SCHEMBL9903622

SCHEMBL9903622

O=C(O)CC[C@H](NC(=O)NCCCC[C@H](NCc1ccc(I)cc1)C(=O)O)C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2475977 1.00 FOLH1 (0.74) FOLH1
SCHEMBL4336030 0.90 FOLH1 (0.72) FOLH1
SCHEMBL19748291 0.87 FOLH1 (0.69) FOLH1
SCHEMBL19748972 0.86 FOLH1 (0.68) FOLH1
Iofolastat SCHEMBL2475975 0.85 FOLH1 (1.00) FOLH1
Iofolastat SCHEMBL9903616 0.85 FOLH1 (1.00) FOLH1
Iofolastat SCHEMBL20496027 0.85 FOLH1 (1.00) FOLH1
Iofolastat SCHEMBL18493678 0.85 FOLH1 (1.00) FOLH1
SCHEMBL19747822 0.85 FOLH1 (0.70) FOLH1
SCHEMBL4326624 0.84 FOLH1 (0.91) FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057614-A1 COMBINATION THERAPIES WITH PSMA LIGAND CONJUGATES Psma Development Company, L.L.C. (US) 2016-08-24 — — EP disclosed
WO-2015073896-A2 BIOMARKERS FOR PSMA TARGETED THERAPY FOR PROSTATE CANCER PSMA DEVELOPMENT COMPANY, LLC (US) 2015-05-21 — — WO disclosed
WO-2015057250-A1 COMBINATION THERAPIES WITH PSMA LIGAND CONJUGATES PSMA DEVELOPMENT COMPANY, LLC (US) 2015-04-23 — — WO disclosed
EP-2648766-A1 PSMA-TARGETED DENDRIMERS Molecular Insight Pharmaceuticals (US) 2013-10-16 — — EP disclosed
WO-2012078534-A1 PSMA-TARGETED DENDRIMERS MOLECULAR INSIGHT PHARMACEUTICALS (US) 2012-06-14 — — WO disclosed
Send feedback